Evidence map›Paper›PMID 27927007›Full record

ArticleMolecules and cells2016

Ginsenoside Re Inhibits Osteoclast Differentiation in Mouse Bone Marrow-Derived Macrophages and Zebrafish Scale Model.

Chan-Mi Park, Hye-Min Kim, Dong Hyun Kim, Ho-Jin Han, Haneul Noh, Jae-Hyuk Jang, Soo-Hyun Park, Han-Jung Chae, Soo-Wan Chae, Eun Kyoung Ryu and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Molecules and cells, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Potential ofChinese herbal medicines · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Pharmacological Properties of Ginsenoside Re.Frontiers in pharmacology · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Bone dynamics in zebrafish on low- and high-frequency diets.Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Chan-Mi ParkWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Hye-Min KimWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Dong Hyun KimWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Ho-Jin HanWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Haneul NohWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Jae-Hyuk JangWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Soo-Hyun ParkClinical Trial Center for Functional Foods (CTCF2), Chonbuk National University Hospital, Jeonju 54907, Korea.
Han-Jung ChaeClinical Trial Center for Functional Foods (CTCF2), Chonbuk National University Hospital, Jeonju 54907, Korea.
Soo-Wan ChaeClinical Trial Center for Functional Foods (CTCF2), Chonbuk National University Hospital, Jeonju 54907, Korea.
Eun Kyoung RyuCenter of Magnetic Resonance Research, Korea Basic Science Institute, Cheongju 28119, Korea.
Sangku LeeWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Kangdong LiuWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Haidan LiuWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Jong-Seog AhnWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Young Ock KimDepartment of Medicinal Crop Research Institute, National Institute of Horticultural & Herbal Science, Rural Development Administration, Eumseong 27709, Korea.
Bo-Yeon KimWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Nak-Kyun SoungWorld Class Institute (WCI), and Chemical biology Research Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju 28116, Korea.
Korea University of Science and Technology · KRJeonbuk National University Hospital · KRRural Development Administration · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginsenosides, which are the active materials of ginseng, have biological functions that include anti-osteoporotic effects. Aqueous ginseng extract inhibits osteoclast differentiation induced by receptor activator of NF-κB ligand (RANKL). Aqueous ginseng extract produces chromatography peaks characteristic of ginsenosides. Among these peaks, ginsenoside Re is a major component. However, the preventive effects of ginsenoside Re against osteoclast differentiation are not known. We studied the effect of ginsenoside Re on osteoclast differentiation, RANKL-induced tartrate-resistant acid phosphatase (TRAP) activity, and formation of multinucleated osteoclasts

Indexed as

AnimalsBone Marrow CellsCell DifferentiationGinsenosidesMacrophagesMiceOsteoclastsZebrafishginsenoside ReGinsenosidesginsenoside ReosteoclastsRANKLzebrafish

Identifiers

PMID27927007
PMCPMC5223102
OpenAlexW2563527352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.